$35M QVAR Inhaler Settlement Resolves Teva Pharmaceuticals Antitrust Lawsuit
May 6, 2026 A $35M QVAR settlement ends a class action lawsuit that alleges Teva illegally sought to block competition for its inhaler products.
Lawsuit Filings
Opioid Class Action Lawsuit Claims Big Pharma, Pharmacy Chains Fueled Nationwide Epidemic
March 7, 2024 A class action alleges a longstanding conspiracy among big pharma to grow the prescription painkiller market effectively fueled the opioid epidemic.
Takeda, Par, Watson, Amneal Conspired to Suppress Competition for Generic Gout Treatment, Class Action Claims
August 9, 2021 Another class action alleges Takeda and Par have conspired to suppress competition in the generic drug market, this time for Colcrys (colchicine).
Healthcare Plans Join Ranks of Those Suing Big Pharma Over Opioid Crisis
June 13, 2019 Two healthcare plans have joined the ranks of those suing Big Pharma heavyweights over their alleged contributions to the national opioid crisis that has devastated the nation.
Lawsuit Claims ER Doctors Forced to Bear Costs of Opioid-Related Medical Treatment
July 26, 2018 Another lawsuit has been filed against a group of pharma companies and distributors that claims their allegedly deceptive marketing of opioids has resulted in ER physicians being paid little to no compensation for providing opioid-related treatment.
Class Action: Opioid Manufacturers, Distributors Caused ‘The Worst Drug Crisis in American History’
June 21, 2018 A proposed class action claims 14 pharmaceutical companies' and wholesale distributors' allegedly deceptive marketing of opioids has led to what public health officials are calling 'the worse drug crisis in American history.'
Opioid Lawsuit Filed on Behalf of Infant Born with NAS Lands in Louisiana Federal Court
April 26, 2018 Another proposed class action filed on behalf of children born with Neonatal Abstinence Syndrome accuses a group of pharmaceutical companies and distributors of contributing to the 'opioid epidemic' that has swept across the state of Louisiana.
Another Lawsuit Seeking to Address ‘Opioid Epidemic’ Added to Growing MDL
March 30, 2018 Another proposed class action filed on behalf of a minor child diagnosed with NAS has been added to the multidistrict litigation involving pharmaceutical companies’ and distributors’ alleged contributions to the country’s growing 'opioid epidemic.'
Latest Opioid Case Filed in West Virginia on Behalf of Newborn Baby
March 9, 2018 A growing number of lawsuits have been filed against a group of pharmaceutical companies and distributors over claims that the defendants have caused a national health crisis by deceptively marketing opioids for long-term use.
Class Action Claims Pharma Companies Responsible for NAS Due to Opioid Use
March 6, 2018 A group of 20 pharmaceutical companies and distributors has been named in a proposed class action lawsuit filed on behalf of a newborn baby who the suit claims suffers from neonatal abstinence syndrome (NAS) as a result of the defendants’ actions.
Teva Accused of Misleading Investors About Acquisition’s Success
December 6, 2017 Teva Pharmaceutical Industries Ltd. and three executives have been named as defendants in a proposed class action lawsuit that accuses them of violating federal securities laws by publishing false statements regarding their financial projections.
Nearly 20 Pharma Giants Named in Antitrust Class Action Lawsuit Over National Opioid Epidemic
December 5, 2017 Three Mississippi hospitals claim the conduct of 19 pharma-industry heavyweights contributed greatly to the nation's opioid abuse epidemic.